Jane Martin

Jane Martin, PhD



Psychology, Alzheimer's Disease

Research Topic:

Alzheimer's Disease

Dr. Martin is an Associate Professor of Psychiatry and Director of the Clinical Neuropsychology Division in the Department of Psychiatry at the Mount Sinai School of Medicine.  She is the Director of the Neuropsychology Testing and Evaluation Center (Neuropsychology Services) and the Adult Psychology Pre-doctoral Training Program in the Department of Psychiatry.  She received her Ph.D. in Psychology from New York University and completed a post-doctoral fellowship in Neuropsychology at Mount Sinai School of Medicine.   She teaches in the Memory Enhancement Program, a wellness program for older adults, and also maintains a psychotherapy practice.  Dr. Martin is a neuropsychologist at Mount Sinai's Alzheimer's Disease Research Center (ADRC), as well as being an accomplished clinician and administrator of neuropsychological clinical services.

As Director of the Neuropsychological Testing and Evaluation Center, she provides neuropsychological assessment for memory disorders and teaches, "Introduction to Neuropsychological Assessment in Psychiatry and Geriatric Psychiatry".  Dr. Martin conducts and supervises neuropsychological assessments, in addition to teaching and lecturing on the topic of neuropsychological testing and memory and aging.  Dr. Martin's research interests include healthy aging in the elderly, Alzheimer's disease and related dementias, and women's cognitive changes throughout the lifespan.  She receives research support from Mount Sinai's ADRC (Alzheimer's Disease Research Center) and the ADCS Project (Alzheimer's Disease Cooperative Study Site).  Currently, she is Co-Investigator for a study about the Therapeutic Effects of Exercise in Adults with Amnestic Mild Cognitive Impairment at the ADRC (GCO # in process) as well as Co-Investigator for A Phase 2 Multi Center, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients with Mild to Moderate Alzheimer’s Disease (GCO#91-208) and Co-Investigator for  A Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Simultaneously Qualify a Biomarker Algorithm for Prognosis of Risk of Developing Mild Cognitive Impairment due to Alzheimer’s Disease (MCI due to AD) and to Test the Safety and Efficacy of Pioglitazone (AD 4833SR 0.8mg QD) to Delay the Onset of MCI due to AD in Cognitively Normal Subjects (TOMM40) (GCO# 13-1688).  She wass PI for a multi-center 4-year longitudinal study to evaluate home-based methods for Alzheimer's disease prevention research (GCO #91-208(13) and  is the center neuropsychologist and co-investigator for a study of deep brain stimulation for treatment of obsessive compulsive disorder (GCO #09-1479) in the department of Psychiatry.

Financial & Billing Information

Please direct any detailed billing or financial inquires to the Mount Sinai Psychiatry billing customer service number at 212-659-8752.

Clinical Focus


PhD, New York University

Internship, Psychology, Mount Sinai Hospital

Fellowship, Clinical Neuropsychology, Mount Sinai Hospital

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.